Design and expression of a stable bispecific scFv dimer with affinity for both glycoprotein and N9 neuraminidase

Molecular Immunology

Volumn 33, Issue 17-18, 1996, Pages 1301-1312

  Atwell, John L ^a   Pearce, Lesley A ^a   Maria, Lah ^a   Clem Gruen, L ^a   Kortt, Alexander A ^a   Hudson, Peter J ^a  

^a CSIRO   (Australia)

Author keywords

antibody fragments; BIAcore(TM); bisFv; bispecific single chain antibody dimer; diabody; glycophorin; neuraminidase; scFv

Indexed keywords

BISPECIFIC ANTIBODY; GLYCOPHORIN; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN FV FRAGMENT; SIALIDASE; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ARTICLE; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTIBODIES, BISPECIFIC; ANTIBODY AFFINITY; ANTIGENS; BINDING SITES, ANTIBODY; BIOSENSING TECHNIQUES; CHROMATOGRAPHY, GEL; DIMERIZATION; GLYCOPHORIN; HEMAGGLUTINATION TESTS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; NEURAMINIDASE; PROTEIN ENGINEERING;

ERWINIA; ESCHERICHIA COLI;

EID: 0030434862     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00097-1     Document Type: Article

References (49)

1. Beck E., Sommer R., Auerswald E. A., Kurz C., Zink B., Osterburg G., Schaller H., Sugimoto K., Sugisaki H., Okamoto T. and Takanami M. (1978) Nucleotide sequence of bacteriophage fd DNA. Nucl. Acids Res. 5, 4495-4503.
2. Brizzard B. L., Chubet R. G. and Vizard D. L. (1994) Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. BioTechniques 16, 730-734.
3. Burton D. R. and Barbas C. F. (1994) Human antibodies from combinatorial libraries. Adv. Immun. 57, 191-280.
4. Carrier A., Ducancel F., Settiawan N. B., Cattolico L., Maillère B., Léonetti M., Drevet P., Ménez A. and Boulain J. C. (1995) Recombinant antibody alkaline phosphatase conjugates for diagnosis of human IgGs: application to anti-HBsAg detection. J. Immun. Meth. 181, 177-186.
5. Carter P., Bedouelle H. and Winter G. (1985) Improved oligonucleotide site directed mutagenesis using M13 vectors. Nucl. Acids Res. 13, 4431-4443.
6. Coia G., Hudson P. J. and Lilley G. G. (1996) Construction of recombinant extended single-chain antibody peptide conjugates for use in the diagnosis of HIV1 and HIV2. J. Immun. Meth. 192, 13-23.
7. Colman P. M., Tulip W. R., Varghese J. N., Baker A. T., Tulloch P. A., Air G. M. and Webster R. G. (1987) Three dimensional structures of influenza virus neuraminidase-antibody complexes. Phil. Trans. Roy. Soc. Lond. (series B) 323, 511-518.
8. Gill S. C. and Hippel P. H. von (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326.
9. Glockshuber R., Malia M., Pfitzinger I. and Plückthun A. (1990) A comparison of strategies to stabilize immunoglobulin Fv fragments. Biochemistry 29, 1362-1367.
10. Gruber M., Schodin B. A., Wilson E. R. and Kranz D. M. (1994) Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli. J. Immun. 152, 5368-5374.
11. Gruen L. C., Kortt A. A. and Nice E. (1993) Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology. Eur. J. Biochem. 217, 319-325.
12. Gussow D. and Clackson T. (1989) Direct clone characterization from plaques and colonies by PCR. Nucl. Acids Res. 17, 4000.
13. Hanahan D. (1983) Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166, 557-580.
14. Holliger P., Prospero T. and Winter G. (1993) "Diabodies": small bivalent and bispecific antibody fragments. Proc. natn. Acad. Sci. U.S.A. 90, 6444-6448.
15. Holliger P., Brissinck J., Williams R. L., Thielemans K. and Winter G. (1996) Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Prot. Eng. 9, 299-305.
16. Hopp T. P., Prickett K. S., Price V. L., Libby R. T., March C. J., Cerretti D. P., Urdal D. L. and Conlon P. J. (1988) A short polypeptide marker sequence useful for recombinant protein identification and purification. BioTechnology 6, 1204-1210.
17. Hudson P. (1995) Structure and application of single-chain Fvs as diagnostic and therapeutic agents. In: Monoclonal Antibodies: The Second Generation. (Edited by Zola H.), pp. 183-292. BIOS Scientific, Oxford, U.K.
18. Huston J. S., Mudgett-Hunter M., Tai M. S., McCartney J. E., Warren F. D., Haber E. and Oppermann H. (1991) Protein engineering of single chain Fv analogs and fusion proteins. Meth. Enzym. 203, 46-88.
19. Jonsson U., Fagerstam L., Lofas S., Stenberg E., Karlsson R., Frostel A., Markey F. and Schindler F. (1993) Introducing a biosensor based technology for real time biospecific interaction analysis. Ann. Biol. Clin. 51, 19-26.
20. Karlsson R., Michelsson A. and Mattsson L. (1991) Kinetic analysis of monoclonal and antigen-antibody interactions with a new biosensor based analytical system. J. Immun. Meth. 145, 229-240.
21. Karlsson R., Roos H., Fagerstam L. and Persson B. (1994) Kinetic and concentration analysis using BIA technology. Methods (Meth. Enzym. part II) 6, 99-110.
22. Kemp B. E., Rylatt D. B., Bundesen P. G., Doherty R. R., McPhee D. A., Stapleton D., Cottis L. E., Wilson K., John M. A., Khan J. M., Dinh D. P., Miles S. and Hillyard C. J. (1988) Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood. Science 241, 1352-1354.
23. Kipriyanov S. M., Dübel S., Breitling F., Kontermann R. E. and Little M. (1994) Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies. Mol. Immun. 31, 1047-1058.
24. Kortt A. A., Malby R. L., Caldwell J. B., Gruen L. C., Ivancic N., Lawrence M. C., Howlett G. J., Webster R. G., Hudson P. J. and Colman P. M. (1994) Recombinant antineuraminidase single chain Fv antibody: characterization, formation of dimer and higher molecular mass multimers and the solution of the crystal structure of the scFv-neuraminidase complex. Eur. J. Biochem. 221, 151-157.
25. Kurucz I., Titus J. A., Jost C. R., Jacobus C. M. and Segal D. M. (1995) Retargetting of CTL by an efficiently refolded bispecific single chain dimer produced in bacteria. J. Immun. 154, 4576-4582.
26. Laemmli U. and Favre M. (1973) Maturation of the heads of bacteriophage T4. I. DNA packaging events. J. Mol. Biol. 80, 575-599.
27. Lilley G. G., Dolezal O., Hillyard C. J., Bernard C. and Hudson P. J. (1994) Recombined single chain antibody polypeptide conjugates expressed in E. coli for the rapid diagnosis of HIV. J. Immun. Meth. 211, 211-226.
28. Mack M., Riethmuller G. and Kufer P. (1995) A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc. natn. Acad. Sci. U.S.A. 92, 7021-7025.
29. Malby R. L., Caldwell J. B., Gruen L. C. Harley V. R., Ivancic N., Kortt A. A., Lilley G. G., Power B. E., Webster R. G., Colman P. M. and Hudson P. J. (1993) Recombinant antineuraminidase single chain antibody: expression, characterization and crystallisation in complex with antigen. Prot. Struct. Funct. Gen. 16, 57-63.
30. Malby R. L., Tulip W. R., Harley V. R., McKimm-Breschin J. L., Laver W. G., Webster R. G. and Colman P. M. (1994) The structure of a complex between the NC10 antibody and the influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. Structure 2, 733-746.
31. Mallender W. D. and Voss E. W. (1994) Construction, expression and activity of a bivalent bispecific single chain antibody. J. Biol. Chem. 269, 199-206.
32. Marks J. D., Griffith A. D., Malmquist M., Clackson T. P., Bye J. M. and Winter G. (1992) By-passing immunization: Building high affinity human antibodies by chain shuffling. BioTechnology 10, 779-783.
33. 2 made by protein folding and bonded through C-terminal cysteinyl peptides. Prot. Eng. 8, 310-314.
34. McGregor D. P., Molloy P. E., Cunningham C. and Harris W. J. (1994) Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Mol. Immun. 31, 219-226.
35. McKimm-Breschkin J. L., Caldwell J. B., Guthrie R. E. and Kortt A. A. (1991) A new method for the purification of influenza A virus neuraminidase. J. Virol. Meth. 32, 121-124.
36. Metzger D. W. and Webster R. G. (1990). In: Idiotype Networks in Biology and Medicine (Edited by Osterhaus A. D. M. E. and Uytdellaag F. G. C. M.), pp. 257-267, Elsevier B. V.
37. Neri D., Momo M., Prospero T. and Winter G. (1995) High-affinity antigen binding by chelating recombinant antibodies. J. Mol. Biol. 246, 367-373.
38. Pack P., Muller K., Zahn P. and Plückthun A. (1995) Tetravalent minibodies with high avidity assembling in E. coli. J. Mol. Biol. 246, 28-34.
39. Perisic O., Webb P. A., Holliger P., Winter G. and Williams R. L. (1994) Crystal structure of a diabody, a bivalent antibody fragment. Structure 2, 1218-1226.
40. H domain in Escherichia coli using the pelB secretion signal. Gene 113, 95-99.
41. Rylatt D. B., Kemp B. E., Bundesen P. G., John M. A., O'Reilly E. J., Cottis L. E., Miles S. J., Khan J. M., Dinh D. P., Stapleton D. and Hillyard C. J. (1990) A rapid whole-blood immunoassay system. Med. J. Aust. 152, 75-77.
42. Towbin H., Staehlin T. and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. natn. Acad. Sci. U.S.A. 76, 4350-4354.
43. Wang L.-F., Yu M., White J. R. and Eaton B. T. (1996) Btag: a novel six-residue epitope tag for surveillance and purification of recombinant proteins. Gene 169, 53-58.
44. Whitlow M., Filpula D., Rollence M. L., Feng S. L. and Woods J. F. (1994) Multivalent Fvs: characterisation of single-chain Fv oligomers and preparation of a bispecific Fv. Prot. Eng. 7, 1017-1026.
45. Wilson K. M., Gerometta M., Rylatt D. B., Bundesen P. G., McPhee D. A., Hillyard C. J. and Kemp B. E. (1991) Rapid whole blood assay for HIV-1 seropositivity using an Fab-peptide conjugate. J. Immun. Meth. 138, 111-119.
46. Winter G., Griffiths A. D., Hawkins R. E. and Hoogenboom H. R. (1994) Making antibodies by phage display technology. Ann. Rev. Immun. 12, 433-455.
47. Wu A. M., Chen W., Raubitschek A., Williams L. E., Neumaier M., Fischer R., Hu S.-Z., Odom-Maryon T., Wong J. Y. C. and Shively J. E. (1996) Tumor localization of anti-CEA single chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2, 21-36.
48. Zdanov A., Li Y., Bundle D. R., Deng S.-J., MacKenzie C. R., Narang S. A., Young N. M. and Cygler M. (1994) Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7 Å resolution. Proc. natn. Acad. Sci. U.S.A. 91, 6423-6427.
49. Zhu Z., Zapata G., Shalaby R., Snedecor B., Chen H. and Carter P. (1996) High level secretion of a humanised bispecific diabody from E. coli. BioTechnology 14, 192-196.